Problem statement: Answer the MCQ question.
Query: Which compound exhibits a 6.431% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) C=CCN(C(=O)c1csnn1)C(C(=O)NCc1ccc(F)cc1)c1ccccc1
b) C/C(Cn1cnc([N+](=O)[O-])n1)=N\NC(=O)c1cccc(F)c1
Answer: b. C/C(Cn1cnc([N+](=O)[O-])n1)=N\NC(=O)c1cccc(F)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(Cn1cnc([N+](=O)[O-])n1)=N\NC(=O)c1cccc(F)c1
C/C(Cn1cnc([N+](=O)[O-])n1)=N\NC(=O)c1cccc(F)c1
3-fluoro-N-[(E)-1-(3-nitro-1,2,4-triazol-1-yl)propan-2-ylideneamino]benzamide